Palacios R, Möller G, Claesson L, Peterson P A
Immunogenetics. 1981;14(5):367-82. doi: 10.1007/BF00373317.
Antisera directed against the heavy, the light, or reactive against the complex of both chains of HLA-DR antigens strongly inhibited proliferation of T cells induced by TNP- or FITC-labeled autologous cells when added at initiation of the cultures, but not 72 h later. T cells from cultures treated with the anti-DR sera were unresponsive to interleukin-2 (IL-2). Nonetheless, the anti-DR sera did not inhibit proliferation of T cells that had already acquired sensitivity to IL-2. The DR antibodies abrogated the synthesis of IL-2 induced by both TNP-and FITC-conjugated autologous cells. Treatment of TNP-and FITC-labeled autologous cell cultures with the four different types of anti-DR sera significantly inhibited the induction of cytotoxic T cells. However, DR antibodies added at the effector phase of cytotoxicity assays did not inhibit the cytotoxic activity. Effector T cells from cultures treated with the anti-DR sera were unresponsive to IL-2 and addition of IL-2 to these cultures did not restore the cytotoxic activity. In contrast, effector T cells from cultures performed in the absence of the anti-DR sera proliferated to Il-2 stimulation and addition of IL-2 to these cultures significantly increased the generation of killer cells specific for hapten-labeled self structures. From these results we concluded the following: (1) Both the heavy and the light chains of Dr antigens participate actively in the activation of T cells by rendering resting T cells sensitive to IL-2 and by inducing production of the growth factor in TNP-and FITC-conjugated autologous cell cultures. (2) The heavy and light chains of the DR antigens play an essential role in the induction of cytotoxic T cells specific for hapten-labeled self structures, most likely by enabling cytotoxic T cells to respond to Il-2 and by inducing the IL-2 producer T cells to synthesize the growth factor.
针对HLA - DR抗原重链、轻链或针对两条链复合物起反应的抗血清,在培养开始时加入会强烈抑制由TNP或FITC标记的自体细胞诱导的T细胞增殖,但在72小时后加入则无此作用。用抗DR血清处理的培养物中的T细胞对白细胞介素 - 2(IL - 2)无反应。然而,抗DR血清并不抑制已经对IL - 2产生敏感性的T细胞的增殖。DR抗体消除了由TNP和FITC偶联的自体细胞诱导的IL - 2的合成。用四种不同类型的抗DR血清处理TNP和FITC标记的自体细胞培养物,显著抑制了细胞毒性T细胞的诱导。然而,在细胞毒性测定的效应阶段加入DR抗体并不抑制细胞毒性活性。用抗DR血清处理的培养物中的效应T细胞对IL - 2无反应,向这些培养物中加入IL - 2并不能恢复细胞毒性活性。相反,在没有抗DR血清的情况下进行培养的效应T细胞对IL - 2刺激有增殖反应,向这些培养物中加入IL - 2显著增加了对半抗原标记的自身结构具有特异性的杀伤细胞的生成。从这些结果我们得出以下结论:(1)DR抗原的重链和轻链都通过使静止T细胞对IL - 2敏感并在TNP和FITC偶联的自体细胞培养物中诱导生长因子的产生,积极参与T细胞的激活。(2)DR抗原的重链和轻链在对半抗原标记的自身结构具有特异性的细胞毒性T细胞的诱导中起重要作用,最有可能是通过使细胞毒性T细胞对IL - 2作出反应并诱导产生IL - 2的T细胞合成生长因子。